Skip to content

Effect of Agnimantha Shilajatu Yoga in Obesity(Sthoulya)

Pharmaceutical Standardization of Agnimantha Shilajatu Yoga prepared by using Agnimantha Patra Swarasa & Twaka Kwatha and their comparative efficacy in Sthoulya (Obesity)- An Open Label Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051475
Enrollment
64
Registered
2023-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients present with classical signs and symptom of Sthoulya 2. BMI 25kg/m2 to 35kg/m2 will be selected for the study. 3. WHR i.e., Waist Hip Circumference ratio >0.95 in males and >0.8 in females will be selected. 4. Obesity-associated dis-lipidemic patients included in the study.

Exclusion criteria

Exclusion criteria: 1. BMI below 25kg/m2 and above 35kg/m2 are excluded. 2. Pregnancy and lactation 3. Obesity secondary to or associated with hypothyroidism,hypertension,diabetes mellitus, Cushing syndrome and other endocrine disorders. 4. Patients suffering from psychiatric illness are excluded. 5. Any concomitant serious disorders of liver, kidneys, heart, lungs or other organs. 6. Patient undergoing treatment for any other serious illness.

Design outcomes

Primary

MeasureTime frame
1. Development of Standard Manufacturing Process of Agnimantha patra swarasa and twaka kwatha bhavita Shilajatu. 2. Evaluation of clinical efficacy of Agnimantha patra swarasa and twaka kwatha bhavita Shilajatu in Sthoulya (Obesity) by determining classical symptoms, biochemical parameters and 7.5% reduction in weight.Timepoint: The time of assessment will be as follows: For objective criteria:baseline(0th day),60th day. For subjective criteria:baseline(0th day),15thday, 30th day,45thday,60th day and follow up on 90th day

Secondary

MeasureTime frame
Development of preliminary analytical profile of Agnimantha patra swarasa and twaka kwatha bhavita Shilajatu.Timepoint: It will take 6months to assess analytical profile of drug

Countries

India

Contacts

Public ContactProfVdP K Prajapati

ALL INDIA INSTITUTE OF AYURVEDA 11007

prajapati.pradeep1@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026